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Intravascular Hemolysis Due to Suspected
Continuous-Flow LVAD ThrombosisNowell M. Fine, MD,* Yan Topilsky, MD,* Jae K. Oh, MD,* Tal Hasin, MD,*
Sudhir S. Kushwaha, MD,* Richard C. Daly, MD,y Lyle D. Joyce, MD, PHD,y
John M. Stulak, MD,y Naveen L. Pereira, MD,* Barry A. Boilson, MD,*
Alfredo L. Clavell, MD,* Brooks S. Edwards, MD,* Soon J. Park, MD, MSy
Rochester, MinnesotaOBJECTIVES This study sought to characterize the echocardiographic ﬁndings of patients present-
ing with intravascular hemolysis (IVH) due to suspected continuous-ﬂow left ventricular assist device
(LVAD) pump thrombosis.
BACKGROUND LVAD patients who develop pump thrombosis often present with IVH. Echocardiog-
raphy may be able to detect device dysfunction in this setting.
METHODS Continuous-ﬂow LVAD patients presenting with IVH due to suspected pump thrombosis
were identiﬁed. Patients underwent echocardiography with cannula Doppler ﬂow velocity interrogation.
Findings were compared with baseline and follow-up studies, and with 49 stable LVAD control patients.
RESULTS Of 145 patients, 14 (10%) had IVH due to suspected pump thrombosis. The mean age was
55  15 years, 93% were men, and 50% received LVAD as destination therapy. Mean duration between
implantation and IVH was 231  218 days. Eleven (79%) patients presented with hemoglobinuria, 9 (64%)
with jaundice, and 5 (36%) with acute heart failure. Reduced cannula diastolic ﬂow velocity and increased
systolic/diastolic (S/D) ﬂow velocity ratio were the only echocardiographic parameters signiﬁcantly
different from controls (outﬂow cannula 0.3  0.2 m/s vs. 0.8  0.3 m/s, p ¼ 0.03, and 5.9  2.8 vs.
1.7  0.7, p < 0.01, respectively), and were worse for IVH patients with acute heart failure compared
with those without (outﬂow cannula 0.2  0.1 m/s vs. 0.5  0.2 m/s, p ¼ 0.04, and 7.2  3.3 vs. 5.3 
2.0, p ¼ 0.02, respectively). Outﬂow cannula diastolic ﬂow velocity and S/D ﬂow velocity ratio
changed signiﬁcantly from baseline (p ¼ 0.01 and p < 0.01, respectively) in IVH patients, whereas systolic
ﬂow velocity did not change (p¼ 0.59). Odds ratios for outﬂow cannula diastolic ﬂow velocity and S/D ﬂow
velocity ratio for predicting IVH were 0.60 (95% conﬁdence interval [CI]: 0.51 to 0.73), p ¼ 0.02, and 2.45
(95% CI: 2.37 to 2.52) p< 0.01, respectively. Corresponding inﬂow cannula values were similarly signiﬁcant.
Pump thrombosis was conﬁrmed in 7 (50%) patients after LVAD retrieval.
CONCLUSIONS Reduced cannula diastolic ﬂow velocity and increased S/D ﬂow velocity ratio iden-
tiﬁed continuous-ﬂow LVAD dysfunction in patients with IVH due to suspected pump thrombosis better
than other echocardiographic parameters. (J Am Coll Cardiol Img 2013;6:1129–40)ª 2013 by the American
College of Cardiology Foundation
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BTT = bridge to transplant
DT = destination therapy
IAS = interatrial septum
IVH = intravascular hemoly
IVS = interventricular sept
LAP = left atrial pressure
LVAD = left ventricular
assist device
PI = pulsatility index
RAP = right atrial pressure
S/D = systolic/diastolic
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1130ontinuous-ﬂow left ventricular assist devices or DT were included. Of 158 patients, we excluded
(LVAD) provide circulatory support and
improve survival for patients with ad-
vanced heart failure (HF) (1–3). These
devices have demonstrated improved durability and
outcomes compared with older pulsatile LVADs,
and currently are the preferred device model for
patients with indications for LVAD implantation
(1). Initially implanted as a bridge to transplantation
(BTT), LVADs are increasingly used for the pur-
pose of destination therapy (DT) (1).
Pump thrombosis is increasingly recognized as
an important complication in patients supported by
continuous-ﬂow LVADs, and is associated with a
high degree of morbidity and mortality (1,2,4).
Patients with pump thrombosis frequently present
with signs and symptoms of intravascular hemolysis
(IVH) (1). Pump thrombosis may be associated
with LVAD dysfunction impairing left ventricularFrom the *D
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um(LV) unloading and circulatory support,
and can lead to clinical HF and/or he-
modynamic instability.
Pump thrombosis is often diagnosed in
the presence of clinical and biochemical
signs of IVH, accompanied by changes
in device parameters such as increased
power levels. Echocardiography is an im-
portant tool for the evaluation of device
and cardiac function in LVAD-supported
patients (5), and echocardiographic pa-
rameters associated with adverse outcomes
have been previously described (6). The
role of echocardiography in the evaluation
of patients presenting with IVH due tosuspected pump thrombosis is poorly deﬁned. The
purpose of this study was to characterize the echo-
cardiographic ﬁndings of patients presenting with
IVH due to suspected continuous-ﬂow LVAD
pump thrombosis.
METHODS
Study population. We retrospectively reviewed the
records of all patients with prior implantation of a
HeartMate II continuous-ﬂow LVAD (Thoratec
Corporation, Pleasanton, California) followed at our
center between January 2008 and December 2012.
Patients implanted with an LVAD as either BTTivision of Cardiovascular Diseases, Department of Medicine,
ar Surgery, Department of Surgery, Mayo Clinic, Rochester, Min
d consulting services for Thoratec Corporation. All other author
his paper to disclose.
eceived April 12, 2013; revised manuscript received June 7, 20113 who died at the time of implantation or in the
perioperative period, for a ﬁnal study population
of 145. All patients provided written informed
consent granting access to their medical records for
research purposes. The Mayo Clinic Institutional
Review Board approved this study.
Intravascular hemolysis due to suspected LVAD
pump thrombosis. Patients presenting with IVH
due to suspected pump thrombosis were selected for
further analysis. This was deﬁned as an acute rise in
serum lactate dehydrogenase $2-fold above the
stable baseline level while on LVAD support in
conjunction with elevated free plasma hemoglobin
(>12 mg/dl) in the absence of other causes of he-
molysis, accompanied by at least 1 of the following:
1) left-sided HF in the absence of other causes; or 2)
acute or gradual increases in pump power of $2 W
above the stable baseline level. Patients presenting
with IVH due to suspected pump thrombosis were
initially treated with intensiﬁed anticoagulation and
then monitored for evidence of persistent or wors-
ening IVH and/or end-organ dysfunction. Surgical
device exchange or urgent heart transplantation was
recommended for patients with signs of clinical or
hemodynamic instability or worsening IVH and/or
end-organ dysfunction. Intensiﬁed anticoagulation
consisted of intravenous unfractionated heparin and
intensiﬁed antiplatelet therapy with increased as-
pirin dose and/or addition of an oral platelet
P2Y12 receptor blocker. An intravenous glycopro-
tein IIb/IIIa inhibitor was added for patients with
persistent clinical and/or biochemical IVH who
remained stable without end-organ dysfunction.
Clinical and demographic data. The routine sur-
veillance follow-up protocol after LVAD implanta-
tion at our institution has been previously described
(6). Brieﬂy, all patients underwent monthly clinical
outpatient follow-up for the ﬁrst 3 months after
discharge from hospital, and then every 3 to 4months
thereafter unless otherwise indicated. Comprehen-
sive clinical, laboratory, device, and echocardio-
graphic data were collected at each surveillance
encounter, and these data were also collected at the
time of presentation with IVH due to suspected
pump thrombosis. Device data included pump
speed, power, ﬂow, and pulsatility index (PI) (a
measure of the magnitude of blood ﬂow pulsesMayo Clinic, Rochester, Minnesota; and the yDivision of
nesota. Dr. Daly holds a patent with Neochord, Inc. Dr. Park
s have reported that they have no relationships relevant to the
3, accepted June 13, 2013.
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1131through the pump occurring with LV contraction).
Echocardiographic data collected at IVH presenta-
tion were compared with baseline, deﬁned as the
most recent prior stable surveillance encounter. If a
patient presented with IVH before a surveillance
encounter occurred, data collected at the time of
hospital discharge following LVAD implantation
were considered baseline. Echocardiographic data at
IVH presentation were also compared with the sub-
sequent follow-up study after treatment.
Echocardiographic measurements. Transthoracic
echocardiography was performed using a stan-
dardized LVAD clinical protocol using an iE33
(Philips Medical Systems, Andover, Maryland),
Sequoia 512 (Siemens Medical Solutions, Malvern,
Pennsylvania), or Vivid 7 or E9 (GE Healthcare,
Milwaukee, Wisconsin) ultrasound system (5). LV
intracavitary and wall thickness dimensions were
measured using 2-dimensional imaging at the
papillary muscle level from the parasternal short-
axis view (7). Left ventricular ejection fraction
(LVEF) was calculated by the Quinones method
(8) assuming an akinetic apex, and LV mass was
calculated by the method proposed by DevereuxFigure 1. LVAD Inﬂow and Outﬂow Cannula With Doppler Flow Wa
Suspected Pump Thrombosis
Echocardiographic images from a left ventricular assist device (LVAD)-s
with the inﬂow cannula (IC) visualized at the apex; (B) Doppler ﬂow w
diastolic (D) (white arrow) ﬂow velocities during normal device function
with intravascular hemolysis (IVH) due to suspected pump thrombosis d
ﬂow velocity due to impaired device contribution to ﬂow through the p
ﬂow into the aorta (Ao) from the same patient; (E) systolic and diastolic
the time of IVH due to suspected pump thrombosis, again illustrating preet al. (9). Mitral inﬂow deceleration time was
measured using pulsed-wave (PW) Doppler ﬂow
imaging. Valvular regurgitation was qualitatively
graded using color-ﬂow Doppler imaging ac-
cording to American Society of Echocardiography
guidelines as follows: normal/trivial ¼ 1; mild ¼ 2;
moderate ¼ 3; and severe ¼ 4 (10).
Right ventricular (RV) size and systolic function
were evaluated in the apical 4-chamber view, and
RV fractional area change was calculated as: (end-
diastolic area minus the end-systolic area)/end-
diastolic area 100 (11). RV systolic dysfunction was
graded qualitatively as none/normal, mild, moder-
ate, or severe. RV function was also assessed by
tricuspid annular plane systolic excursion measure-
ment using M-mode imaging (11), and RV index of
myocardial performance calculation, as previously
described (12). Pulmonary artery systolic pressure
(PASP) was estimated as: (4  TRVmax2) þ esti-
mated right atrial pressure (RAP), where TRVmax
is the peak systolic continuous-wave Doppler ﬂow
velocity of tricuspid valve regurgitation at end-
expiration. RAP estimation was based on interro-
gation of the inferior vena cava diameter andveforms at Baseline and at Presentation With IVH Due to
upported patient: (A) apical 4-chamber view of the left ventricle (LV)
aveforms from the IC demonstrating systolic (S) (yellow arrow) and
; (C) ﬂow velocities from the same patient at the time of presentation
emonstrating preserved systolic ﬂow velocity with reduced diastolic
ump; (D) right-parasternal view of the outﬂow cannula (OC) showing
ﬂow velocities from the OC during normal LVAD function; and (F) at
served systolic with reduced diastolic ﬂow velocities. LA ¼ left atrium.
Table 1. Clinical, Laboratory, and LVAD Characteristics of LVAD Patients With IVH
Due to Suspected Pump Thrombosis and Stable Control Patients
IVH Patients
(n [ 14)
Controls
(n [ 49) p Value
Clinical characteristics
Age, yrs 55  15 57  13 0.48
Male 13 (93) 45 (92) 0.61
Hypertension 6 (43) 19 (39) 0.17
Diabetes mellitus 7 (50) 12 (24) 0.05
Chronic renal insufﬁciency 7 (50) 22 (45) 0.29
Atrial ﬁbrillation 4 (29) 13 (27) 0.55
Cardiomyopathy etiology 0.36
Ischemic 6 (43) 23 (47)
Dilated 6 (43) 27 (55)
Valvular 1 (7) 0 (0)
Sarcoidosis 1 (7) 0 (0)
Body mass index, kg/m2 30  5 29  5 0.84
Heart rate, beats/min 88  11 75  15 0.04
Blood pressure, systolic or mean, mm Hg 84  15 89  12 0.11
Laboratory characteristics
Hemoglobin, g/dl 9.1  3.0 12.3  1.7 <0.01
Platelets, 109/l 157  175 209  164 <0.01
Bilirubin, mg/dl 1.9  0.8 1.1  0.1 0.02
AST, U/l 198  137 57  84 <0.01
ALT, U/l 271  162 68  79 <0.01
Lactate dehydrogenase, U/l 2,273  1,418 367  138 <0.01
Plasma hemoglobin, mg/dl 48.6  23.7 11.8  9.4 <0.01
INR 1.2  0.9 1.9  0.5 0.03
Creatinine, mg/dl 2.7  1.8 1.3  0.4 0.01
Blood urea nitrogen, mg/dl 42  14 20  7 <0.01
Albumin, g/dl 3.4  0.8 3.6  0.5 0.09
NT-proBNP, pg/ml 2,189  1,208 358  591 <0.01
LVAD characteristics
Time since implant, days 231  218 269  309 0.07
Destination therapy 7 (50) 23 (47) 0.61
Pump speed, rpm 9,507  421 9,483  306 0.57
Pump ﬂow, l/min 5.2  1.7 5.5  0.8 0.20
Pump power, W 7.2  3.6 4.9  1.9 <0.01
Pulsatility index 2.8  2.6 4.8  1.1 <0.01
Values are mean  SD or n (%). p values in bold are statistically signiﬁcant.
ALT ¼ alanine aminotransferase; AST ¼ aspartate aminotransferase; INR ¼ international normalized ratio;
IVH ¼ intravascular hemolysis; LVAD ¼ left ventricular assist device; NT-proBNP ¼ amino terminal pro–B-
type natriuretic peptide; rpm ¼ rotations per minute.
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1132distensibility, and scored as 5, 10, 15, or 20 mm Hg,
as previously described (13).
LVAD echocardiographic measurements. LVAD
speciﬁc echocardiographic measurements performed
on all patients included 2-dimensional visualization
and interrogation of the inﬂow and outﬂowcannula using color-ﬂow and continuous-wave or
PW Doppler ﬂow imaging as previously described
(5,6,14). The inﬂow cannula was evaluated from
the apical 4- and 2-chamber views (Fig. 1). The
outﬂow cannula was evaluated from the high left
parasternal long-axis view or right parasternal view
(with the patient in right lateral decubitus position)
(Fig. 1). Off-axis imaging was sometimes required.
The LVAD echocardiography protocol used at our
laboratory includes documentation in the ﬁnal
report of the optimal transthoracic acoustic imaging
windows used for measuring cannula Doppler ﬂow
velocities, thereby aiding serial assessment. Peak
systolic and nadir diastolic ﬂow velocities were
measured for both the inﬂow and outﬂow cannulas
(Fig. 1), and the ratio of systolic/diastolic (S/D)
ﬂow velocity was calculated (5).
LVAD output was estimated using the product
of the outﬂow cannula PW Doppler velocity–time
integral, and the calculated cross-sectional area
from the cannula diameter measured in the im-
aging views described earlier in the text (6,15).
Total cardiac output (the sum of LVAD output
and native LV output) was estimated using the
product of the RV outﬂow tract PW Doppler
velocity-time integral and the calculated cross-
sectional area from the RV outﬂow tract diam-
eter measured from the parasternal short-axis view
(11). Measures of LV unloading included: end-
diastolic interventricular septum (IVS) position
(neutral, shifted leftward or rightward), and aortic
valve (AV) opening frequency (closed, opens
intermittently, or opens every cardiac cycle).
Mean left atrial pressure (LAP) was estimated
based on estimated RAP and the end-diastolic
interatrial septum (IAS) position: LAP ¼ RAP
if IAS is neutral, LAP ¼ RAP  5 if IAS
is shifted leftward, and LAP ¼ RA P þ 5 if IAS
is shifted rightward, as previously described (6).
Statistical analysis. Data are presented as the mean
 SD for continuous data or as frequency and
percentages for categorical data. Patients with IVH
due to suspected pump thrombosis were compared to
a selected sample of 49 of 52 eligible stable LVAD
control patients (3 were excluded due to suboptimal
image quality) matched with IVH patients by age,
sex, and goal of LVAD therapy (BTT or DT).
Comparisons between patient groups were per-
formed using the Student t test or Wilcoxon rank
sum test for normally and non-normally distributed
data for continuous variables, respectively, and the
Fisher exact test for categorical variables. Data
normality was assessed using the Shapiro-Wilk test.
Changes in echocardiographic variables at different
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1133time points were compared using the Wilcoxon
signed rank test or paired Student t test as indicated.
Odds ratios with 95% conﬁdence intervals were
calculated for the association of echocardiographic
variables with IVH due to suspected pump throm-
bosis. Correlations between echocardiographic vari-
ables and device parameters in IVH patients were
evaluated according to the Pearson correlation coef-
ﬁcient (r). All p values were 2-sided, and a value of
p # 0.05 was considered statistically signiﬁcant.
Statistical analyses were performed using JMP
version 9.0 statistical software (SAS Institute Inc.,
Cary, North Carolina).
RESULTS
Patient characteristics. Of 145 patients in the study
population, 14 (10%) had IVH due to suspected
pump thrombosis. Clinical, laboratory, and device
characteristics of IVH and stable LVAD control
patients are presented in Table 1. The mean age of
IVH patients was 55  15 years, 93% were men,
and 50% received LVAD as DT. The mean time
between LVAD implantation and IVH was 231 
218 days. Twelve (86%) IVH patients presented
with subtherapeutic international normalized ratio
levels; 5 cases occurred following interruption of
anticoagulation due to a recent bleeding event, and
2 in anticipation of an elective procedure. Two pa-
tients developed IVH despite therapeutic interna-
tional normalized ratio levels. All patients had
biochemical evidence of IVH (Table 1), 11 pre-
sented with hemoglobinuria and 9 with jaundice.
Ten (71%) patients presented with device parameter
abnormalities, including 10 with increased power
levels and 9 with decreased PIs.
Echocardiographic characteristics. Echocardiographic
characteristics of IVH and stable LVAD control
patients are presented in Table 2. IVH patients
trended towards having larger LVs, worse LVEF, and
lower mitral inﬂow deceleration times compared
with control patients. Measures of RV enlargement
and systolic function were also worse in IVH pa-
tients, and estimated PASP was higher.
LVAD echocardiographic characteristics. LVAD-
speciﬁc echocardiographic measurements were
feasible in all IVH patients and are compared with
the measurements in stable LVAD control patients
in Table 2. Although systolic velocities were similar
between groups for both the inﬂow and outﬂow
cannulas, diastolic velocities were signiﬁcantly lower
for IVH patients, suggesting impaired device
contribution to ﬂow through the pump (Fig. 1).
This resulted in a signiﬁcantly higher S/D velocityratio for the inﬂow (p ¼ 0.01) and outﬂow
(p < 0.01) cannulas. Estimated LVAD and total
cardiac output trended towards being lower for IVH
patients, who also more often had a rightward IVS
shift and AV opening, both reﬂecting less efﬁcient
LV unloading. IAS position and estimated LAP
were similar between groups.
Because patients who presented with acute
decompensated HF at the time of IVH due to
suspected pump thrombosis were felt to have more
clinically signiﬁcant LVAD dysfunction and
impaired LV unloading, echocardiographic charac-
teristics of IVH patients presenting with (n ¼ 5)
and without (n ¼ 9) acute HF were compared
(Table 3). Acute HF was deﬁned as the presence
of new pulmonary edema and/or pleural effusions
on chest x-ray, or the need for either intrave-
nous diuretics or inotrope therapy. Patients with
acute HF trended towards having larger LVs and
lower LVEF than those without HF. Patients
with acute HF had lower diastolic velocities for
the inﬂow and outﬂow cannulas in addition to
higher S/D velocity ratios, although this difference
was only signiﬁcant for the outﬂow cannula (p ¼
0.04 and p ¼ 0.02, respectively). In keeping with
less efﬁcient LV unloading, IVH patients with
acute HF trended towards having a more right-
ward IVS shift and regular AV opening than those
without.
Cannula diastolic velocity and S/D velocity ratio
correlated with device power level for IVH patients
(inﬂow cannula: diastolic velocity r ¼ 0.73, p ¼
0.04; S/D velocity ratio r ¼ 0.70, p ¼ 0.04; outﬂow
cannula: diastolic velocity r ¼ 0.79, p ¼ 0.02;
S/D velocity ratio r ¼ 0.81, p < 0.01), whereas only
S/D velocity ratios correlated with PI (inﬂow
cannula: r ¼ 0.77, p ¼ 0.03; outﬂow cannula:
r ¼ 0.78, p ¼ 0.01). No other echocardiographic
parameters correlated with device power or PI
(Online Table 1).
Treatment and outcomes. All patients were hospi-
talized at IVH presentation and treated with
intensiﬁed anticoagulation. IVH resolved with-
out complication in 7 (50%) patients with inten-
siﬁed anticoagulation. Of the remaining 7 patients:
1 went for urgent device exchange surgery, 2 de-
clined urgent device exchange surgery (both were
DT LVAD patients) and subsequently died (1 due
to intracranial hemorrhage and 1 severe HF),
and 4 went for urgent heart transplantation. All
5 patients who went for device exchange or heart
transplantation survived. Pump thrombus was
conﬁrmed by inspection in all 7 patients under-
going device explantation. Patients who required
Table 2. Echocardiographic Characteristics of LVAD Patients With IVH Due to Suspected Pump Thrombosis and
Stable Control Patients
IVH Patients
(n [ 14)
Controls
(n [ 49) p Value
Standard echocardiographic parameters
LV end-diastolic diameter, mm 64  8 60  9 0.18
LV end-systolic diameter, mm 53  11 51  10 0.52
LV septal wall thickness, mm 10  2 9  3 0.70
LV posterior wall thickness, mm 10  3 10  3 0.75
LV ejection fraction, % 24  9 28  15 0.23
LV mass, g 290  176 308  199 0.82
Mitral inﬂow deceleration time, ms 142  79 164  90 0.07
Mitral inﬂow deceleration time <150 ms 8 (57) 20 (41) 0.08
Aortic regurgitation grade 1/4 1/4 0.60
Aortic regurgitation >trivial 4 (29) 12 (24) 0.72
Mitral regurgitation grade 1/4 1/4 0.81
Mitral regurgitation >mild 3 (21) 9 (18) 0.73
RV end-diastolic area, cm2 31  8 29  6 0.21
RV end-systolic area, cm2 22  8 19  7 0.39
RV fractional area change, % 29  15 32  12 0.23
RV $ moderate enlargement 8 (57) 15 (31) 0.03
RV $ moderate systolic dysfunction 9 (64) 16 (33) 0.01
TAPSE, mm 15  4 18  6 0.32
RIMP 0.37  0.24 0.28  0.13 0.20
Tricuspid regurgitation grade 2/4 1/4 0.28
Tricuspid regurgitation >mild 6 (43) 18 (37) 0.33
Tricuspid regurgitation velocity, m/s 2.5  0.3 2.3  0.3 0.44
Estimated RAP, mm Hg 12  5 9  4 0.25
Estimated PASP, mm Hg 40  18 33  15 0.27
Continued on the next page
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1134device removal had lower diastolic velocities
for the inﬂow (0.1  0.1 m/s vs. 0.3  0.1 m/s,
p ¼ 0.06) and outﬂow (0.1  0.1 m/s vs. 0.4  0.1
m/s, p ¼ 0.03) cannula, and higher S/D velocity
ratios for the inﬂow (3.3  1.1 vs. 2.6  0.8,
p ¼ 0.02) and outﬂow (7.5  2.7 vs. 5.0  1.9,
p < 0.01) cannulas than those who improved
with intensiﬁed anticoagulation.
Serial echocardiographic characteristics. Serial echo-
cardiographic characteristics for IVH patients are
presented in Table 4. The mean duration between
echocardiograms performed at baseline and IVH
presentation was 127  82 days, and between the
IVH and follow-up studies, was 76  21 days. The
2 patients who died and 1 who had urgent device
exchange surgery did not have follow-up echocardi-
ography available for comparison. In comparison
with baseline, 13 (93%) patients had reduced inﬂow
and outﬂow cannula diastolic velocities at IVHpresentation, all of whom also had increased S/D
velocity ratios. Among patients with follow-up
echocardiography, improvements in both parameters
were observed in 10 patients (91%). By comparison,
8 (57%) patients had increased LV end-diastolic
diameter and 4 (29%) had increased frequency of
AV opening from baseline to IVH presentation, with
follow-up improvement occurring in 3 and 2 pa-
tients, respectively.
Mean inﬂow and outﬂow cannula diastolic veloc-
ities (Fig. 2) and S/D velocity ratio (Fig. 3) signiﬁ-
cantly declined and increased, respectively, from
baseline to IVH presentation, and generally returned
close to baseline values in follow-up (Table 4). By
comparison, diastolic velocity (Fig. 2) and S/D
velocity ratio (Fig. 3) did not signiﬁcantly change in
stable LVAD control patients over time. Serial
changes in other parameters reﬂecting LVAD
function and LV unloading were not statistically
Table 2. Continued
IVH Patients
(n [ 14)
Controls
(n [ 49) p Value
LVAD echocardiographic parameters
Inﬂow cannula systolic ﬂow velocity, m/s 0.8  0.3 0.9  0.3 0.72
Inﬂow cannula diastolic ﬂow velocity, m/s 0.2  0.2 0.6  0.4 0.01
Inﬂow cannula systolic/diastolic ﬂow velocity ratio 2.9  1.4 1.6  0.7 0.01
Outﬂow cannula systolic ﬂow velocity, m/s 1.5  0.3 1.6  0.5 0.59
Outﬂow cannula diastolic ﬂow velocity, m/s 0.3  0.2 0.8  0.3 0.03
Outﬂow cannula systolic/diastolic ﬂow velocity ratio 5.9  2.8 1.8  0.7 <0.01
LVAD output, l/min 4.3  2.1 4.9  1.3 0.28
Total cardiac output, l/min 4.8  2.2 5.6  1.6 0.20
Interventricular septum position 0.18
Rightward 3 (21) 2 (4)
Neutral 10 (71) 41 (84)
Leftward 1 (8) 6 (12)
Aortic valve opening frequency 0.20
Closed 7 (50) 35 (71)
Opens intermittently 3 (22) 11 (23)
Opens 4 (28) 3 (6)
Interatrial septum position 0.25
Rightward 2 (14) 2 (4)
Neutral 11 (79) 39 (80)
Leftward 1 (7) 8 (16)
Estimated LAP, mm Hg 11  5 9  5 0.31
Values are mean  SD or n (%). p values in bold are statistically signiﬁcant.
LAP ¼ left atrial pressure; LV ¼ left ventricular; PASP ¼ pulmonary artery systolic pressure; RAP ¼ right atrial pressure; RIMP ¼ right ventricular index of myocardial
performance; RV ¼ right ventricular; TAPSE ¼ tricuspid annular plane systolic excursion; other abbreviations as in Table 1.
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1135signiﬁcant in IVH patients (Table 4). Lastly, odds
ratios with 95% conﬁdence intervals associating
echocardiographic parameters with IVH due to
suspected pump thrombosis are presented in
Table 4. The diastolic velocity and S/D velocity
ratio were signiﬁcantly associated with IVH for
both the inﬂow and outﬂow cannulas.
D I SCUSS ION
This study demonstrates that patients with Heart-
Mate II (Thoratec Corporation) continuous-ﬂow
LVADs presenting with IVH due to suspected
pump thrombosis have distinct echocardiographic
ﬁndings that differentiate them from stable LVAD
patients. Most signiﬁcant among these are reduced
cannula diastolic velocity with preserved systolic
velocity, resulting in an increased S/D velocity ratio.
Serial echocardiograms in IVH patients showed that
cannula diastolic velocity and S/D velocity ratio
abnormalities were greater at the time of IVH incomparison with baseline and improved with reso-
lution of the clinical syndrome after treatment. We
also found that these parameters were more
abnormal in IVH patients presenting with acute HF
and in those requiring device removal, likely
reﬂecting a greater degree of LVAD dysfunction.
This study provides important insights into the
interpretation of Doppler ﬂow waveforms acquired
from the inﬂow and outﬂow cannula during echo-
cardiography in continuous-ﬂow LVAD patients.
A continuous signal with systolic peaks and dias-
tolic nadirs reﬂects the characteristic blood ﬂow
pattern through the pump that is the hallmark
of continuous-ﬂow devices. LV contraction in-
creases blood ﬂow through the pump, resulting in
an increased systolic cannula velocity. Diastolic ve-
locity is independent of LV contraction and reﬂects
ﬂow through the pump that is generated by the
LVAD alone. This explains why in the setting of
suspected pump thrombus and device dysfunction,
diastolic ﬂow is the predominant waveform affected,
Table 3. Echocardiographic Characteristics of LVAD Patients With IVH Due to
Suspected Pump Thrombosis Presenting With and Without Acute HF
IVH Patients
With Acute HF
(n [ 5)
IVH Patients
Without Acute HF
(n [ 9) p Value
LV end-diastolic diameter, mm 64  9 62  8 0.15
LV end-systolic diameter, mm 53  10 52  12 0.67
LV ejection fraction, % 23  9 25  9 0.82
Mitral inﬂow deceleration time, ms 140  88 146  72 0.20
Estimated PASP, mm Hg 40  18 39  17 0.42
Inﬂow cannula systolic ﬂow velocity, m/s 0.8  0.3 0.9  0.4 0.94
Inﬂow cannula diastolic ﬂow velocity, m/s 0.2  0.1 0.3  0.1 0.74
Inﬂow cannula systolic/diastolic ﬂow velocity ratio 3.1  1.6 2.8  1.3 0.12
Outﬂow cannula systolic ﬂow velocity, m/s 1.4  0.2 1.5  0.6 0.83
Outﬂow cannula diastolic ﬂow velocity, m/s 0.2  0.1 0.5  0.2 0.04
Outﬂow cannula systolic/diastolic ﬂow velocity ratio 7.2  3.3 5.3  2.0 0.02
LVAD output, l/min 4.3  2.1 4.2  1.8 0.64
Total cardiac output, l/min 4.1  2.0 5.5  2.4 0.16
Interventricular septum position 0.28
Rightward 3 0
Neutral 2 8
Leftward 0 1
Aortic valve opening frequency 0.11
Closed 0 7
Opens intermittently 2 1
Opens 3 1
Interatrial septum position 0.75
Rightward 1 1
Neutral 4 7
Leftward 0 1
Estimated LAP, mm Hg 11  3 12  6 0.88
Values are mean  SD or n. p values in bold are statistically signiﬁcant.
HF ¼ heart failure; other abbreviations as in Tables 1 and 2.
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1136with the degree of reduction likely reﬂecting the
degree of thrombus interference with pump func-
tion. Systolic velocity is less affected, and in our
study, was relatively preserved in most patients
despite reduced diastolic velocity. In the setting of
worsening LV contractility, systolic velocity will fall.
The observed correlation between LVAD PI and
cannula S/D velocity ratio reinforces this principle
because both parameters reﬂect the device’s relative
contribution to ﬂow through the pump along with
changes in loading conditions.
Our study demonstrates that LVAD cannula
Doppler ﬂow interrogation is a useful noninvasive
tool for evaluating patients with IVH due to sus-
pected pump thrombosis, particularly when values
can be compared with previous echocardiogramsperformed during periods of normal device function.
Cannula diastolic velocity and S/D velocity ratio
could potentially be used to grade the severity of
device dysfunction when pump thrombosis is sus-
pected. The ﬁnding of improvement in these pa-
rameters following treatment with intensiﬁed
anticoagulation suggests they could be used to assess
response to treatment in patients who do not require
urgent surgical device exchange. The utility of these
parameters for guiding therapy in this setting war-
rants further research.
This is the ﬁrst study, to our knowledge, to report
comprehensive serial echocardiographic ﬁndings in
LVAD patients with IVH due to suspected pump
thrombosis. Our center previously described ranges
of multiple echocardiographic variables in stable
Table 4. Serial Echocardiographic Findings in LVAD Patients Presenting With IVH Due to Suspected Pump Thrombosis and
Odds Ratios of Echocardiographic Parameters for Predicting IVH
Baseline
(n [ 14)
IVH
(n [ 14)
Follow-Up
(n [ 11) p Value* OR (95% CI, p Value)
LV end-diastolic diameter, mm 62  7 64  8 63  10 0.43 1.19 (0.89–1.42, p ¼ 0.27)
LV end-systolic diameter, mm 51  9 53  11 53  10 0.92 1.05 (0.78–1.22, p ¼ 0.31)
LV ejection fraction, % 22  10 23  9 22  8 0.74 1.14 (0.82–1.35, p ¼ 0.37)
Mitral inﬂow deceleration time, ms 149  90 142  79 145  99 0.19 0.71 (0.34–1.17, p ¼ 0.29)
Estimated PASP, mm Hg 36  16 40  18 37  17 0.35 1.21 (0.95–1.37, p ¼ 0.21)
Inﬂow cannula systolic ﬂow velocity, m/s 0.8  0.4 0.8  0.3 0.9  0.4 0.77 1.02 (0.73–1.11, p ¼ 0.18)
Inﬂow cannula diastolic ﬂow velocity, m/s 0.5  0.3 0.2  0.1 0.4  0.2 0.02 0.69 (0.58–0.77, p [ 0.03)
Inﬂow cannula systolic/diastolic ﬂow velocity ratio 1.6  0.5 2.9  1.4 2.0  0.6 <0.01 2.01 (1.82–2.21, p < 0.01)
Outﬂow cannula systolic ﬂow velocity, m/s 1.5  0.4 1.5  0.3 1.4  0.2 0.59 1.07 (0.73–1.14, p ¼ 0.24)
Outﬂow cannula diastolic ﬂow velocity, m/s 0.7  0.2 0.3  0.1 0.6  0.2 0.01 0.60 (0.51–0.73, p [ 0.02)
Outﬂow cannula systolic/diastolic ﬂow velocity ratio 2.0  0.3 5.9  3.8 2.6  0.3 <0.01 2.45 (2.37–2.52, p < 0.01)
LVAD output, l/min 4.6  2.7 4.3  2.1 4.4  2.7 0.15 0.87 (0.62–1.16, p ¼ 0.30
Total cardiac output, l/min 5.0  3.1 4.8  2.2 4.9  2.5 0.30 0.92 (0.70–1.23, p ¼ 0.42)
Interventricular septum position 0.28 1.10 (0.73–1.30, p ¼ 0.37)
Rightward 0 (0) 2 (14) 0 (0)
Neutral 13 (93) 11 (79) 10 (91)
Leftward 1 (7) 1 (7) 1 (9)
Aortic valve opening frequency 0.25 1.21 (0.90–1.41, p ¼ 0.10)
Closed 10 (58) 7 (50) 9 (82)
Opens intermittently 4 (28) 3 (22) 1 (9)
Opens 0 (14) 4 (28) 1 (9)
Interatrial septum position 0.23 1.13 (0.79–1.24, p ¼ 0.31)
Rightward 0 (0) 1 (7) 0 (0)
Neutral 11 (79) 11 (79) 10 (91)
Leftward 3 (21) 2 (14) 1 (9)
Estimated LAP, mm Hg 10  3 11  5 11  4 0.40 1.02 (0.54–1.29, p ¼ 0.19)
Values are mean  SD or n (%). Values in bold are statistically signiﬁcant. *Comparison of baseline and IVH presentation values.
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Tables 1 and 2.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 1 1 , 2 0 1 3 Fine et al.
N O V E M B E R 2 0 1 3 : 1 1 2 9 – 4 0 Echocardiography in Suspected LVAD Thrombosis
1137patients with normally functioning HeartMate II
(Thoratec Corporation) LVADs, including systolic
and diastolic velocities for both the inﬂow and
outﬂow cannulas (5). Topilsky et al. (6) later
described echocardiographic variables associated
with poor 90-day outcomes following LVAD im-
plantation. That study found that measures of RV
systolic function and measures of LV unloading,
including mitral inﬂow deceleration time, estimated
LAP, and IAS position, predicted outcome. None
of those variables were signiﬁcantly associated with
IVH due to suspected pump thrombosis in our
study, even though this condition can also lead to
impaired LV unloading. This difference may be due
to a smaller number of patients included in our
study. Their study also included patients withnormally functioning LVADs, unlike patients in
our study who likely had varying degrees of device
dysfunction. Accordingly, adverse outcomes in their
study were largely due to RV failure or bleeding
complications (1 patient died from embolic stroke,
although it is not clear whether that patient also had
device thrombosis). We found cannula Doppler
ﬂow interrogation to be more accurate in the setting
of suspected pump thrombosis, variables that were
not evaluated in their study. Neither study found
LV dimensions, LVEF, AV opening frequency, or
calculated LVAD or total cardiac output were
signiﬁcantly associated with outcome.
The recently published Ramp study (4) describes
a standardized protocol for optimizing LVAD
pump speed based on graded speed increases under
Figure 2. Serial LVAD Inﬂow and Outﬂow Cannula Diastolic Flow Velocities in IVH Patients and Stable LVAD Control Patients
Comparison of serial diastolic Doppler ﬂow velocities from the inﬂow (top) and outﬂow (bottom) cannula in LVAD patients with IVH due to
suspected pump thrombosis (green) and stable LVAD control patients (pink) at baseline, at presentation, and in follow-up. p values above the
curves (black) compare values between IVH and control patients, whereas p values below the curves compare serial measurements at
different time points for IVH (green) and control (pink) patients. Abbreviations as in Figure 1.
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1138echocardiographic guidance. Changes in echocar-
diographic variables along with device parameters
are recorded after each pump speed increase, and
the slope of each parameter’s linear function plot is
used to select the pump speed that optimizes LV
unloading. This protocol proved safe and effective
for 39 patients with HeartMate II (Thoratec
Corporation) LVADs included in the study. The
protocol was also shown to be accurate for the
detection of pump thrombosis when used in combi-
nation with lactate dehydrogenase levels in 17 pa-
tients with suspected pump thrombosis. Although
the use of echocardiography-guided ramp studies is
generally recommended in the literature for opti-
mizing pump speed in LVAD patients (16), their use
in the setting of suspected pump thrombosis varies
widely among LVAD implanting centers. We pre-
sent a different and possibly complementary echocar-
diographic approach for detecting device dysfunction
due to pump thrombosis that can be performed quickly
and without the need for multiple measurements at
different pump speeds. Further research is needed to
determine whether cannula ﬂow velocity measure-
ments provide incremental diagnostic or prognostic
value in this setting. In the Ramp study, 53% of pa-
tients with suspected pump thrombosis requireddevice removal, similar to the 50% in our study. Of
those patients who did not require device removal
in the Ramp study (4), pump speed ramp studies
were used to determine which received intensiﬁed
anticoagulation and which were monitored for IVH
resolution on their pre-existing anticoagulation
regimen. In our study, device removal was recom-
mended in the setting of clinical or hemodynamic
instability or worsening end-organ dysfunction
(such as renal failure secondary to IVH), and all
patients who did not require urgent surgery received
intensiﬁed anticoagulation. The ﬁnding of worse
cannula Doppler ﬂow velocity proﬁles in patients
presenting with acute HF and those requiring de-
vice removal further suggests these parameters
may be useful for guiding management in this
setting, although larger studies are needed to con-
ﬁrm this.
Study limitations. This was a single-center, retro-
spective, observational study, and so the presence of
bias cannot be excluded. The limited number of
patients presenting with IVH may have resulted
in some potentially important echocardiographic
associations not reaching statistical signiﬁcance.
Validation of these results by a larger multicenter
study is warranted. This same limitation prevented
Figure 3. Serial LVAD Inﬂow and Outﬂow Cannula S/D Flow Velocity Ratios in IVH Patients and Stable LVAD Control Patients
Comparison of serial systolic/diastolic (S/D) Doppler ﬂow velocity ratios from the inﬂow (top) and outﬂow (bottom) cannulas in LVAD patients
with IVH due to suspected pump thrombosis (green) and stable LVAD control patients (pink) at baseline, at presentation, and in follow-up.
p values above the curves (black) compare values between IVH and control patients, whereas p values below the curves compare serial
measurements at different time points for IVH (green) and control (pink) patients.
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1139performance of multivariable analysis to determine
which echocardiographic variables were indepen-
dently associated with IVH due to suspected pump
thrombosis. Thus, although both the cannula dia-
stolic velocity and S/D velocity ratio were signiﬁ-
cantly associated with IVH due to suspected pump
thrombosis, it remains uncertain whether calcula-
tion of the S/D ratio adds incremental value to
measurement of cannula velocities alone in this
setting. Because the S/D velocity ratio reﬂects the
relative contribution of both the device and the
native LV to ﬂow through the pump, we hypothe-
size that this ratio may be a better measure of the
global hemodynamic impact of device dysfunction
secondary to pump thrombosis, particularly for pa-
tients presenting with acute HF. Although our
study demonstrated that IVH patients presenting
with acute HF had more deranged echocardio-
graphic ﬁndings and worse clinical outcomes than
those without HF, it lacked the statistical power to
directly determine which echocardiographic vari-
ables were associated with clinical outcome. Though
highly feasible in our study, cannula Doppler ﬂow
velocities may be technically challenging to accu-
rately measure in some LVAD patients. The use of
off-axis imaging and the reporting of optimaltransthoracic acoustic windows for measuring these
parameters at our laboratory aided their feasibility in
this study. Technically difﬁcult imaging in some
LVAD patients may be a barrier to utilizing these
parameters for less experienced echocardiography
laboratories. We did not evaluate clinical or bio-
chemical markers associated with pump thrombosis,
which were beyond the scope of our study and
have been previously well described (4,16). Further
studies incorporating clinical, biochemical, and
echocardiographic variables would be useful for
developing a risk prediction model for LVAD pa-
tients presenting with IVH. Our study included
only HeartMate II (Thoratec Corporation) patients,
and echocardiographic ﬁndings in patients with
IVH due to suspected device thrombosis of other
LVAD models may be different. Lastly, device
thrombus was conﬁrmed by inspection in only one-
half of the patients in this study.
CONCLUS IONS
HeartMate II (Thoratec Corporation) LVAD pa-
tients presenting with IVH due to suspected pump
thrombosis have distinct echocardiographic ﬁnd-
ings that can be used to detect the presence of
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1140device dysfunction. Reduced cannula diastolic
Doppler ﬂow velocity and the resultant increased S/
D ﬂow velocity ratio were the most important
echocardiographic abnormalities found in this
setting, and reﬂect reduced device contribution to
pump ﬂow.These ﬁndings can aid in the noninvasive
assessment and possibly help guide management ofLVAD patients with device dysfunction caused by
suspected pump thrombosis.
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